Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Stage Parkinson's Disease”

Showing 12 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06167681
What this trial is testing

The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease

Who this might be right for
Parkinson Disease
iRegene Therapeutics Co., Ltd. 40
Large-scale testing (Phase 3)Study completedNCT02006121
What this trial is testing

Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease

Who this might be right for
Parkinson's Disease
Britannia Pharmaceuticals Ltd. 107
Large-scale testing (Phase 3)Study completedNCT01631825
What this trial is testing

A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Otsuka Pharmaceutical Co., Ltd. 321
Testing effectiveness (Phase 2)Ended earlyNCT00607451
What this trial is testing

Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia

Who this might be right for
Levodopa-induced Dyskinesia
Neurim Pharmaceuticals Ltd. 8
Early research (Phase 1)Study completedNCT00292227
What this trial is testing

Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
UCB Pharma 130
Testing effectiveness (Phase 2)Study completedNCT06055985
What this trial is testing

Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease

Who this might be right for
Parkinson Disease
UCB Biopharma SRL 207
Early research (Phase 1)Not Yet RecruitingNCT07550374
What this trial is testing

Phase I Clinical Study of NouvNeu001 Injection for the Treatment of Moderate-to-Advanced Parkinson's Disease in Patients Who Have Previously Undergone Deep Brain Stimulation or Deep Brain Nucleus Lesioning Surgery

Who this might be right for
Parkinson's Disease (PD)
iRegene Therapeutics Co., Ltd. 10
Testing effectiveness (Phase 2)Ended earlyNCT00903838
What this trial is testing

A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.

Who this might be right for
Advanced Stage Parkinson's Disease
Abbott Products 37
Large-scale testing (Phase 3)UnknownNCT02605434
What this trial is testing

Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients

Who this might be right for
Parkinson's Disease
Intec Pharma Ltd. 420
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07028632
What this trial is testing

The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)
iRegene Therapeutics Co., Ltd. 30
Large-scale testing (Phase 3)Study completedNCT00145171
What this trial is testing

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

Who this might be right for
Parkinson Disease
Mylan Bertek Pharmaceuticals 56
Testing effectiveness (Phase 2)Study completedNCT01631812
What this trial is testing

A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Otsuka Pharmaceutical Co., Ltd. 130

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation